Multiple silver linings in spite of a soft Q2 24
15/05/24 -"Coloplast reported softer than expected Q2 24 figures. However, with healthy organic growth, the miss reflected FX headwinds, and, hence, was not that worrisome. Importantly, growth was strong across ..."
Pages
59
Language
English
Published on
15/05/24
You may also be interested by these reports :
31/10/24
Amplifon’s Q3 profitability missed the market’s expectations. The mid-single-digit organic sales growth was driven by growth across all regions. ...
30/10/24
bioMerieux’s Q3 organic sales were a beat. The double-digit growth was driven by a healthy contribution from both segments. While the 2024 guidance ...
30/10/24
Clariane’s turnover growth continued to be driven by increases in both volume and pricing across all the business segments and regions. The group ...
30/10/24
Drägerwerk’s Q3 24 numbers were exactly in line with the prelims. Sales were down, with declines across both segments. However, with a book-to-bill ...